In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...

BMS is letting go of 68 employees in Lawrenceville, New Jersey. The pharma has now cut over 1,000 employees there since April ...

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

Changing how biopharmas package their products, how regulators review new drugs and how mutated genes are fixed could make ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

The FDA’s clunky launch of Elsa, an AI tool to increase efficiency, has sparked concern from agency employees and outside ...

In an open letter addressing the Trump administration’s proposed budget cuts to HHS, the executives urged Congress to continue “robust federal funding” for scientific research, which they say will ...

As of Apr. 22, Sage had 338 full-time employees, all of whom will be laid off effective Aug. 22. The layoffs were announced a few weeks after Maryland’s Supernus Pharmaceuticals acquired Sage for up ...

Moderna ’s mRNA vaccine for seasonal influenza, mRNA-1010, outperformed a currently available shot in older adults in a Phase III trial, paving the way not only toward a regulatory submission but also ...

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

The revamped and “more anti-vax skewed ACIP committee” at the CDC “has a bone to pick with mRNA vaccines,” according to ...

The FDA found that data from a single Phase II study were “insufficient” to justify an accelerated approval review for ...